Financials data is unavailable for this security.
View more
Year on year EssilorLuxottica SA grew revenues 3.68% from 24.49bn to 25.40bn while net income improved 6.32% from 2.15bn to 2.29bn.
| Gross margin | 62.34% |
|---|---|
| Net profit margin | 9.38% |
| Operating margin | 12.72% |
| Return on assets | 3.98% |
|---|---|
| Return on equity | 5.98% |
| Return on investment | 4.88% |
More ▼
Cash flow in EURView more
In 2023, EssilorLuxottica SA increased its cash reserves by 30.51%, or 598.00m. The company earned 4.86bn from its operations for a Cash Flow Margin of 19.14%. In addition the company used 1.72bn on investing activities and also paid 2.43bn in financing cash flows.
| Cash flow per share | 11.89 |
|---|---|
| Price/Cash flow per share | 19.75 |
| Book value per share | 85.66 |
|---|---|
| Tangible book value per share | -5.09 |
More ▼
Balance sheet in EURView more
| Current ratio | 0.8847 |
|---|---|
| Quick ratio | 0.6224 |
| Total debt/total equity | 0.3055 |
|---|---|
| Total debt/total capital | 0.2313 |
More ▼
Growth rates in EUR
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 22.29% and 5.16%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 1.49% |
|---|---|
| Div growth rate (5 year) | 14.13% |
| Payout ratio (TTM) | 77.89% |
| EPS growth(5 years) | 4.52 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 17.11 |
More ▼
